Press release
Leading Growth Driver in the Onychomycosis Market in 2025: Rising Diabetic Population Fuels Onychomycosis Market Growth Driver's Influence
Onychomycosis Market
The increasing population of diabetes patients is anticipated to drive the growth of the onychomycosis market in the future. Diabetes, a chronic disease, arises due to either inadequate production of insulin by the pancreas or inefficient use of insulin by the body. Onychomycosis is a typical foot issue among people with diabetes. It can be managed by avoiding and addressing potential complications linked with onychomycosis. Consequently, the growing prevalence of diabetes underlines a rise in the need for the onychomycosis market. For instance, the UK's National Health Service recognized 549,000 additional individuals at risk of developing type 2 diabetes in June 2024-an increase of almost 20% compared to the 3,065,825 total in 2022. They estimated a total of 3,615,330 people with non-diabetic hyperglycemia or prediabetes registered with a GP. Therefore, the escalating diabetes cases are fuelling the expansion of the onychomycosis market.
Get Your Onychomycosis Market Report Here:
https://www.thebusinessresearchcompany.com/report/onychomycosis-global-market-report
How will the growth rate of the onychomycosis market shape industry trends by 2034?
In recent times, there has been a robust expansion in the size of the onychomycosis market. It is anticipated that the market size will increase from $3.63 billion in 2024 to $3.83 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.4%. This growth during the historical period can be credited to a handful of treatment choices available, an older population, a rising number of diabetes cases, the mushrooming of the pharmaceutical sector, and heightened awareness about fungal infections.
In the coming years, the onychomycosis market size is projected to experience robust growth, surging to $4.81 billion in 2029 with a compound annual growth rate (CAGR) of 5.9%. The expected growth during the forecast period is largely due to the implementation of mixed drug therapies, escalating healthcare spending, expansion of awareness initiatives for onychomycosis, widespread telemedicine services, and advancements in topical drug development. Key trends for the forecast period include the incorporation of digital technologies into onychomycosis identification and treatment, growth in the availability of over-the-counter (OTC) antifungal products, creation of patient-centric treatment methods, focus on individualized medicine in onychomycosis therapy, and the partnering of pharmaceutical corporations for research and development purposes.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12197&type=smp
What trends are poised to drive the future success of the onychomycosis market?
The onychomycosis market is witnessing an increase in product innovation, a central trend that's rapidly gaining traction. Major players in the onychomycosis market are focusing on the creation of revolutionary products to maintain their market standing. For example, Vanda Pharmaceuticals Inc., a biopharmaceutical organization based in the US, declared in January 2024 that the Food and Drug Administration (FDA) has given approval to VTR-297, a treatment for onychomycosis. VTR-297 is a histone deacetylase (HDAC) inhibitor, a small molecule that displays antifungal activity especially against dermatophytes and other fungi, which are crucial in effectively dealing with the pathogens causing onychomycosis. The medication is structured for topical utilization, making it possible to apply directly on the infected nails. This localized method of delivery lessens systemic exposure and possible side effects linked to oral antifungal treatments.
Which primary segments of the onychomycosis market are driving growth and industry transformations?
The onychomycosis market covered in this report is segmented -
1) By Type: Distal Subungual Onychomycosis (DSO), White Superficial Onychomycosis (WSO), Proximal Subungual Onychomycosis (PSO), Candida Onychomycosis, Other Types
2) By Treatment: Drug Treatment, Topical Therapy, Other Treatments
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Distal Subungual Onychomycosis (DSO): Dermatophyte Infections, Mixed Infections
2) By White Superficial Onychomycosis (WSO): Trichophyton Mentagrophytes Infections, Other Non-Dermatophyte Infections
3) By Proximal Subungual Onychomycosis (PSO): Associated with Nail Psoriasis, Fungal Infections In Immunocompromised Patients
4) By Candida Onychomycosis: Candidal Nail Infections, Mixed Fungal-Candida Infections
5) By Other Types: Total Nail Dystrophy, Secondary Onychomycosis
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12197
Which geographical regions are pioneering growth in the onychomycosis market?
North America was the largest region in the onychomycosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onychomycosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the influential players reshaping the onychomycosis market landscape?
Major companies operating in the onychomycosis market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sandoz International GmbH, Bausch Health Companies Inc., Perrigo Company plc, Galderma Laboratories LP, Aurobindo Pharma Limited, Cipla Inc., Dr.Reddy's Laboratories Ltd., Apotex Inc, Lupin Limited, Amneal Pharmaceuticals Inc., Alembic Pharmaceuticals Inc., Kaken Pharmaceutical Co. Ltd., Mayne Pharma Group Limited, Wockhardt Ltd., Jubilant Cadista Pharmaceuticals Inc., Moberg Pharma AB, Medimetriks Pharmaceuticals Inc., Blueberry Therapeutics Ltd., Hallux Inc., NovaBiotics Ltd., Zydus Cadila Healthcare Limited.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12197&type=smp
What Is Covered In The Onychomycosis Global Market Report?
• Market Size Forecast: Examine the onychomycosis market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the onychomycosis market for a structured understanding.
• Key Players Overview: Analyze major players in the onychomycosis market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the onychomycosis market.
• Segment Contributions: Evaluate how different segments drive overall growth in the onychomycosis market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the onychomycosis market.
• Industry Challenges: Identify potential risks and obstacles affecting the onychomycosis market.
• Competitive Landscape: Review strategic developments in the onychomycosis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Leading Growth Driver in the Onychomycosis Market in 2025: Rising Diabetic Population Fuels Onychomycosis Market Growth Driver's Influence here
News-ID: 3897995 • Views: …
More Releases from The Business Research Company
Segment Analysis and Major Growth Areas in the Isoflavones Market
The isoflavones market is poised for remarkable growth over the coming years, driven by increasing consumer awareness and expanding applications across various industries. With rising interest in health supplements and natural ingredients, this market is attracting significant attention from manufacturers and investors alike. Let's delve into the market's size, key players, emerging trends, and segment breakdowns shaping its trajectory.
Projected Market Size and Growth Outlook for Isoflavones
The isoflavones market…
Key Strategic Developments and Emerging Changes Shaping the Infant Nutrition Mar …
The infant nutrition market is on track for substantial expansion in the coming years, driven by evolving consumer preferences and advancements in product offerings. As parents increasingly seek high-quality nutrition solutions tailored to their babies' needs, the sector is poised for remarkable growth through innovative products and diverse distribution channels. Let's explore the market's size projections, key players, emerging trends, and segment breakdowns shaping this dynamic industry.
Projected Growth Trajectory and…
Leading Companies Advancing Innovation and Growth in the Immune Health Supplemen …
The immune health supplements sector is gaining significant traction as consumers increasingly prioritize wellness and preventive care. With a growing interest in personalized nutrition and plant-based options, this market is set to expand rapidly. Let's explore the expected market size, key players, emerging trends, and segmentation that define the future of immune health supplements.
Projected Expansion of the Immune Health Supplements Market by 2030
The immune health supplements market is…
Honey Spread Market Overview: Major Segments, Strategic Developments, and Leadin …
The honey spread market is gaining significant momentum as consumers increasingly seek healthier and more flavorful alternatives to traditional spreads. Growing awareness around natural ingredients and sustainability, combined with e-commerce expansion and innovative product offerings, is set to shape the future of this sector. Below, we explore the market's size, key players, emerging trends, and segmentation to provide a comprehensive outlook through 2030.
Robust Expansion Expected in the Honey Spread Market…
More Releases for Onychomycosis
Rising Diabetic Population Fuels Onychomycosis Market Growth: Powering Innovatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Onychomycosis Market Through 2025?
In recent times, the onychomycosis market has experienced robust growth. It is projected to expand from $3.63 billion in 2024 to $3.83 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.4%. The growth seen in…
Rising Diabetic Population Fuels Onychomycosis Market Growth: A Significant Driv …
The Onychomycosis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Onychomycosis Market Size and Projected Growth Rate?
The market for onychomycosis has seen substantial growth in recent times. The market size is predicted to rise from $3.63 billion in 2024 to $3.83 billion…
Onychomycosis Market Insights and Development Trends
The Onychomycosis Market Is Set To Grow At An Estimated CAGR Of 8.5% From 2025 To 2034, Rising From $7.8 Billion In 2024 To $14.5 Billion By 2034.
On March 21, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of Onychomycosis market goods. The market study excludes key regions that are accelerating marketization. This section also gives…
Onychomycosis Treatment Market Size & Share Analysis
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Onychomycosis Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $4.73 billion In 2028 At…
Onychomycosis Therapeutics Market - Empowering Nail Wellness, Inspiring Beautifu …
Newark, New Castle, USA - new report, titled Onychomycosis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Onychomycosis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Onychomycosis Therapeutics market. The report offers an overview of the market, which…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
